MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,000 | -58.3% | 14,799 | -60.8% | 0.00% | – |
Q2 2022 | $12,000 | -87.1% | 37,800 | -81.9% | 0.00% | – |
Q1 2022 | $93,000 | -87.6% | 209,336 | -73.5% | 0.00% | – |
Q4 2021 | $752,000 | +16.0% | 790,204 | +106.3% | 0.00% | – |
Q3 2021 | $648,000 | -34.4% | 383,081 | +8.2% | 0.00% | – |
Q2 2021 | $988,000 | +23.7% | 354,015 | -0.8% | 0.00% | – |
Q1 2021 | $799,000 | +715.3% | 356,828 | +430.6% | 0.00% | – |
Q4 2020 | $98,000 | +113.0% | 67,250 | +118.3% | 0.00% | – |
Q3 2020 | $46,000 | -48.9% | 30,800 | -29.4% | 0.00% | – |
Q2 2020 | $90,000 | +26.8% | 43,641 | +16.9% | 0.00% | – |
Q1 2020 | $71,000 | -74.9% | 37,339 | -62.1% | 0.00% | – |
Q4 2019 | $283,000 | -76.7% | 98,408 | -58.6% | 0.00% | – |
Q3 2019 | $1,213,000 | -58.6% | 237,431 | -35.9% | 0.00% | – |
Q2 2019 | $2,932,000 | +373.7% | 370,189 | +294.4% | 0.00% | – |
Q1 2019 | $619,000 | +255.7% | 93,860 | +200.2% | 0.00% | – |
Q4 2018 | $174,000 | – | 31,261 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |